glp-1 pen Do the new “slimming” drugs deliver better pouch performance? - J Pouch support charity Lilly's KwikPen Delivers Month of

doi: 10.3727/096368915X690279 107 DalySCChemmanamTLohPSGilliganADearAESimpsonRWet al

2a) and protein (Fig

doi: 10.1523/JNEUROSCI.0529-11.2011 75 DuringMJCaoLZuzgaDSFrancisJSFitzsimonsHLJiaoXet al

The program avoids a one-size-fits-all mentality, instead tailoring the medication type, dosage, and treatment length to each patients unique health profile

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T

GLP-1 agonists are being used widely in the UK, but theyre relatively new as a weight management tool